AlphaFold predicted structure
RPIA · P49247

Mean pLDDT
83.7/ 100
Confident
311 residues
Confidence breakdown
- Very high(≥ 90)75%
- Confident(70–90)1%
- Low(50–70)2%
- Very low(< 50)23%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
ribose 5-phosphate isomerase A
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Intellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalWhite matter disorders and cerebral calcification - narrow panel
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
ribose-5-P isomerase deficiency
Disorder of carbohydrate metabolism
hereditary disease
non-melanoma skin carcinoma
Hashimoto thyroiditis
autoimmune disease
skin neoplasm
neurodegenerative disease
hypothyroidism
immune system disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Ribose-5-phosphate isomerase
Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate and participates in the first step of the non-oxidative branch of the pentose phosphate pathway
RPIA · P49247

Mean pLDDT
83.7/ 100
Confident
311 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0